Journal article
Precision epigenetics provides a scalable pathway for improving coronary heart disease care globally
Epigenomics, Vol.15(16), pp.805-818
08/2023
DOI: 10.2217/epi-2023-0233
PMID: 37702023
Abstract
Coronary heart disease (CHD) is the world’s leading cause of death. Up to 90% of all CHD deaths are preventable, but effective prevention of this mortality requires more scalable, precise methods for assessing CHD status and monitoring treatment response. Unfortunately, current diagnostic methods have barriers to implementation, particularly in rural areas and lower-income countries. This gap may be bridged by highly scalable advances in DNA methylation testing methods and artificial intelligence. Herein, we review prior studies of CHD related to methylation alone and in combination with other biovariables. We compare these new methods with established methods for diagnosing CHD. Finally, we outline pathways through which methylation-based testing methods may allow the democratization of improved methods for assessing CHD globally.
Details
- Title: Subtitle
- Precision epigenetics provides a scalable pathway for improving coronary heart disease care globally
- Creators
- Damon Broyles - Sisters of Mercy Health SystemRobert Philibert - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Epigenomics, Vol.15(16), pp.805-818
- DOI
- 10.2217/epi-2023-0233
- PMID
- 37702023
- eISSN
- 1750-192X
- Language
- English
- Electronic publication date
- 09/13/2023
- Date published
- 08/2023
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Psychiatry; Iowa Neuroscience Institute
- Record Identifier
- 9984463080702771
Metrics
3 Record Views